Rituximab for idiopathic membranous nephropathy (IMN): Renal biopsy findings predict response to treatment.

被引：0
|
作者：
Ruggenenti, P
Chiurchiu, C
Brusegan, V
Perna, A
Abbate, M
Remuzzi, G
机构：
[1] Mario Negri Inst Pharmacol Res, Bergamo, Italy
[2] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：528A / 528A
页数：1
相关论文
共 50 条
  • [41] Two cases of idiopathic membranous nephropathy treated with rituximab
    Yoon, Jae Young
    Han, Seung Tae
    Cho, Ajin
    Jang, Hye Ryoun
    Lee, Jung Eun
    Huh, Wooseong
    Kim, Dae Joong
    Oh, Ha Young
    Kim, Yoon-Goo
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (03) : 138 - 141
  • [42] Treatment with Rituximab in Patients with Idiopathic Membranous Nephropathy: A Case Series and Literature Review
    Jeon, Soojee
    Kim, Yong-Lim
    Kim, Chan-Duck
    Choi, Ji-Young
    Cho, Jang-Hee
    Jung, Hee-Yeon
    Lim, Jeong-Hoon
    Noh, Hee Won
    Park, Sun-Hee
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 829 - 830
  • [43] Review on the Role of Therapeutic Rituximab in Idiopathic Membranous Nephropathy
    Alshehri, Dhafer Ahmed
    Alturki, Haifa Mansour
    Al-Qahtani, Faisal Theeb
    Tashkandi, Abdulrauf Abdulatif A.
    Fallatah, Qamar Adel
    Daiwaly, Jullanar Nashat
    Alyami, Bandar Aedh
    Alanzi, Huda Oawid Hedmool
    Alharbi, Njood Abdulsalam Ali
    Gouharji, Noura Adel
    Altowairqi, Nawaf Fahad Abdullah
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (02): : 134 - 138
  • [44] Plasmapheresis combined with rituximab for refractory idiopathic membranous nephropathy
    Ming Wen
    Claudius Küchle
    Oliver Sarkar
    Lutz Renders
    Uwe Heemann
    Christoph Schmaderer
    International Urology and Nephrology, 2014, 46 : 847 - 848
  • [45] Rituximab for idiopathic membranous nephropathy: Who can benefit?
    Ruggenenti, Piero
    Chiurchiu, Carlos
    Abbate, Mauro
    Perna, Annalisa
    Cravedi, Paolo
    Bontempelli, Mario
    Remuzzi, Giuseppe
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04): : 738 - 748
  • [46] Idiopathic Membranous Nephropathy (IMN) - Has Practice or Outcome Changed in the Last 10 Years?
    McQuarrie, E. P.
    Stirling, C.
    SCOTTISH MEDICAL JOURNAL, 2010, 55 (02) : 50 - 51
  • [47] B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab
    Rosenzwajg, Michelle
    Languille, Eva
    Debiec, Hanna
    Hygino, Joana
    Dahan, Karine
    Simon, Tabassome
    Klatzmann, David
    Ronco, Pierre
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 227 - 237
  • [48] HLA-A, B, DR AND BF ALLOTYPES IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY (IMN)
    PAPIHA, SS
    PAREEK, SK
    RODGER, RSC
    MORLEY, AR
    WILKINSON, R
    ROBERTS, DF
    KERR, DNS
    KIDNEY INTERNATIONAL, 1987, 31 (01) : 130 - 134
  • [49] Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
    Ladino, Marco
    Roth, David
    CLINICAL KIDNEY JOURNAL, 2009, 2 (05): : 395 - 397
  • [50] Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient
    Gallon, L.
    Chhabra, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) : 3017 - 3021
12345